| Mrs Eva Ann Ackerman, RN | |
|
1 Harry S Truman Pkwy, Suite 231, Annapolis, MD 21401-7042 | |
| (410) 222-7494 | |
| (410) 222-4080 |
| Full Name | Mrs Eva Ann Ackerman |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Community Health |
| Location | 1 Harry S Truman Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639370885 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1500X | Registered Nurse - Community Health | R092881 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Eva Ann Ackerman, RN 14 Phyllis Dr, Glen Burnie, MD 21060-8127 Ph: () - | Mrs Eva Ann Ackerman, RN 1 Harry S Truman Pkwy, Suite 231, Annapolis, MD 21401-7042 Ph: (410) 222-7494 |
News Archive
A new radiotherapy system at Loyola University Medical Center will offer cancer patients shorter radiation treatments, with pinpoint accuracy and precision.
"It's not brain surgery" is a phrase often uttered to dismiss a job's difficulty, but when the task actually is removing a brain tumor, even the slightest mistake could have serious health consequences. To help surgeons in such high-pressure situations, researchers from Prof. Adam Wax's team at Duke University's Fitzpatrick Institute for Photonics and Biomedical Engineering Department have proposed a way to harness the unique optical properties of gold nanoparticles to clearly distinguish a brain tumor from the healthy, and vital, tissue that surrounds it.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
› Verified 6 days ago
Mrs. Chase Ryan Best, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1302 Colony Dr, Annapolis, MD 21403 Phone: 443-822-4493 | |
Linda Aveni Murray, CRNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Forbes St, Suite 200, Annapolis, MD 21401 Phone: 410-263-6363 Fax: 410-263-4086 | |
Sharlene Howard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Harry S Truman Pkwy, Suite 234, Ms-3103, Annapolis, MD 21401 Phone: 410-222-4082 | |
Ms. Hellen Joan Butler, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Harry S Truman Pkwy Ste 200, Annapolis, MD 21401 Phone: 410-222-7256 | |
Stephanie Bladen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Pkwy, Annapolis, MD 21401 Phone: 410-571-9700 | |
Ms. Cyrilla Bollinger Rohrer, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Harry S Truman Pkwy, Hd 8, Annapolis, MD 21401 Phone: 410-222-4465 | |
Dr. Sarah K Keenan, DNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1125 West St Ste 316, Annapolis, MD 21401 Phone: 240-771-5793 |